Percutaneous treatment of a giant coronary aneurysm using a Symbiot stent

Cardiovasc Revasc Med. 2005 Apr-Jun;6(2):73-4. doi: 10.1016/j.carrev.2005.05.005.

Abstract

Percutaneous treatment of coronary aneurysms has been proven to be a safe and effective alternative to surgery. We report the successful treatment of a giant proximal left circumflex artery aneurysm with distal occlusion in a 76-year-old man using the new generation of covered stent, Symbiot, a polytetrafluoroethylene-covered self-expandable stent (Boston Scientific, Natick, MA).

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angina Pectoris / etiology
  • Angina Pectoris / surgery
  • Aspirin / therapeutic use
  • Blood Vessel Prosthesis Implantation / methods
  • Blood Vessel Prosthesis*
  • Clopidogrel
  • Coated Materials, Biocompatible / therapeutic use
  • Contrast Media / administration & dosage
  • Coronary Aneurysm / diagnosis
  • Coronary Aneurysm / surgery*
  • Coronary Angiography / methods
  • Coronary Vessels / surgery*
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use
  • Polytetrafluoroethylene / therapeutic use
  • Stents* / adverse effects
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Coated Materials, Biocompatible
  • Contrast Media
  • Platelet Aggregation Inhibitors
  • Polytetrafluoroethylene
  • Clopidogrel
  • Ticlopidine
  • Aspirin